N-(3-Trifluoromethylphenyl)anthranilic acid, commonly known as flufenamic acid, is a nonsteroidal anti-inflammatory drug (NSAID) used primarily for the treatment of mild to moderate pain, inflammation, dysmenorrhea, and rheumatoid arthritis. It functions by inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis that contributes to pain and inflammation. The trifluoromethyl group in its structure enhances its biological activity, potency, and metabolic stability. Additionally, it serves as a key intermediate and building block in organic synthesis for developing novel pharmaceutical compounds and therapeutic agents in research and development.